These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12033376)

  • 21. The effect of ion pairing on the skin permeation of amlodipine.
    Jiang Y; Fang L; Niu X; Rui M; He Z
    Pharmazie; 2008 May; 63(5):356-60. PubMed ID: 18557419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin.
    Fang JY; Hung CF; Chiu HC; Wang JJ; Chan TF
    J Pharm Pharmacol; 2003 Aug; 55(8):1175. PubMed ID: 12956910
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of pH and organic ester penetration enhancers on skin permeation kinetics of terbutaline sulfate from pseudolatex-type transdermal delivery systems through mouse and human cadaver skins.
    Panigrahi L; Pattnaik S; Ghosal SK
    AAPS PharmSciTech; 2005 Sep; 6(2):E167-73. PubMed ID: 16353974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of crude palm oil (CPO) and tocotrienol rich fraction (TRF) of palm oil as percutaneous permeation enhancers using full-thickness human skin.
    Singh I; Nair RS; Gan S; Cheong V; Morris A
    Pharm Dev Technol; 2019 Apr; 24(4):448-454. PubMed ID: 30084268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin.
    Fang JY; Hung CF; Chiu HC; Wang JJ; Chan TF
    J Pharm Pharmacol; 2003 May; 55(5):593-601. PubMed ID: 12831501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of formulation variables on the percutaneous permeation of ketoprofen from gel formulations.
    El-Kattan AF; Asbill CS; Kim N; Michniak BB
    Drug Deliv; 2000; 7(3):147-53. PubMed ID: 10989915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
    Roy SD; Gutierrez M; Flynn GL; Cleary GW
    J Pharm Sci; 1996 May; 85(5):491-5. PubMed ID: 8742940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and topical delivery of N-alkyl-N-alkyloxycarbonylaminomethyl prodrugs of a model phenolic drug: acetaminophen.
    Majumdar S; Sloan KB
    Int J Pharm; 2007 Jun; 337(1-2):48-55. PubMed ID: 17257787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of terpene concentrations on the skin penetration of diclofenac sodium.
    Nokhodchi A; Sharabiani K; Rashidi MR; Ghafourian T
    Int J Pharm; 2007 Apr; 335(1-2):97-105. PubMed ID: 17174049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous permeation of N,N-diethyl-m-toluamide (DEET) from commercial mosquito repellents and the effect of solvent.
    Stinecipher J; Shah J
    J Toxicol Environ Health; 1997 Oct; 52(2):119-35. PubMed ID: 9310145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrogen bond and other descriptors for thalidomide and its N-alkyl analogs; prediction of physicochemical and biological properties.
    Abraham MH
    Eur J Pharm Sci; 2004 Mar; 21(4):465-9. PubMed ID: 14998576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of solvent on percutaneous absorption of nonvolatile lipophilic solute.
    Intarakumhaeng R; Li SK
    Int J Pharm; 2014 Dec; 476(1-2):266-76. PubMed ID: 25261711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influences of alkyl group chain length and polar head group on chemical skin permeation enhancement.
    Warner KS; Li SK; Higuchi WI
    J Pharm Sci; 2001 Aug; 90(8):1143-53. PubMed ID: 11536219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penetration enhancers.
    Williams AC; Barry BW
    Adv Drug Deliv Rev; 2004 Mar; 56(5):603-18. PubMed ID: 15019749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transdermal penetration of cytarabine and its 5'-O alkyl ester derivatives.
    Legoabe LJ; Breytenbach JC; N'Da DD; Breytenbach JW
    Med Chem; 2010 Mar; 6(2):108-13. PubMed ID: 20218966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of heat on the percutaneous absorption and skin retention of three model penetrants.
    Akomeah F; Nazir T; Martin GP; Brown MB
    Eur J Pharm Sci; 2004 Feb; 21(2-3):337-45. PubMed ID: 14757507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Modelling of pecutaneous drug permeation and investigation of penetration enhancer effect].
    Csizmazia E; Berkó S; Maroda M; Szabóné RP; Csányi E
    Acta Pharm Hung; 2012; 82(1):15-22. PubMed ID: 22570983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TranScreen-N: Method for rapid screening of trans-ungual drug delivery enhancers.
    Murthy SN; Vaka SR; Sammeta SM; Nair AB
    J Pharm Sci; 2009 Nov; 98(11):4264-71. PubMed ID: 19363796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of permeation enhancers on transdermal delivery of fluoxetine: in vitro and in vivo evaluation.
    Jung E; Kang YP; Yoon IS; Kim JS; Kwon SW; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2013 Nov; 456(2):362-9. PubMed ID: 24012861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.